Error message

The page you requested does not exist. For your convenience, a search was performed using the query news events news 2017 01 20.

Page not found

You are here

Bioethics Grand Rounds -Anna Kirkland, JD, PhD

Wed, June 28, 2017, 12:00pm
Location: 
UH Ford Auditorium

Anna Kirkland, JD, PhD Title –  "The Vaccine Injury Compensation Court and Its Critics"

Presenter –  Anna Kirkland, JD, PhD, Arthur F. Thurnau Professor of Women's Studies and Political Science, University of Michigan

Abstract: The so-called vaccine court is a small special court in the United States Court of Federal Claims that handles controversial claims that a vaccine has harmed someone. The government steps in as the defendant and vaccine manufacturers are protected from liability. In this court, lawyers, activists, judges, doctors, and scientists come together, sometimes arguing bitterly, trying to figure out whether a vaccine really caused a person’s medical problem. Drawing on her recently published book, Vaccine Court: The Law and Politics of Injury (NYU Press, 2016), Prof. Anna Kirkland will discuss the ethical controversies surrounding the vaccine court, from the perspective of anti-vaccine movement activists as well as from the mainstream.

In videos for The Trust Project, bioethicist and sociologist Raymond De Vries explores trust in medicine from a sociological perspective.

In How Trust Shapes the Medical Field: A Sociologist's Perspective, De Vries offers a historical perspective on trust in medicine:

  • What role did industrialization play in changing interpersonal trust?
  • What can we learn about trusting relationships from past societies?

In The Rise of Bioethics in Response to Medical Distrust: Key Findings, De Vries discusses some key research in the field of trust and bioethics:

  • How did the erosion of trust in medicine lead to the rise in the study of bioethics?
  • Does the bureaucracy that comes with research ethics committees enhance or undermine trust?

An another video, Evolution of Trust in Bioethics medical research ethics.

The Trust Project at Northwestern University features scholars and executives exploring Trust in videos that cover theory, research and practice. By combining multiple and diverse perspectives, The Trust Project aspires to illuminate new insights for research and management.

Fri, July 14, 2017

A study by current and former CBSSM faculty and staff was recently highlighted in Horsetalk (NZ). Angela Fagerlin, Thomas Valley, Aaron Scherer, Megan Knaus, Enny Das, and Brian J. Zikmund-Fisher were co-authors on an international study looking at the impact of flu labels (including "Horse Flu" and "Yarramin Flu") and graphics on risk perceptions and behavioral intentions.

 

Jodyn Platt, MPH, PhD, Assistant Professor of Learning Health Sciences, has been named a University of Chicago MacLean Fellow.

As part of the one year Cancer Genomics and Ethics Big Data Science Fellowship she will receive clinical training in the Medical Ethics Summer Intensive Program and conduct a research project with Olufunmilayo Olopade, MD, FACP, Director of the Center for Clinical Cancer Genetics at University of Chicago Medicine.

Platt explains how her work as a fellow will begin: "I would like to systematically observe and interview individuals involved in shaping how data evolves and moves from the patient encounter to the big data enterprise and back to clinical care." Looking forward to expanding her network over the course of the year, she plans "to engage in, and lead, interdisciplinary scholarship that will ensure the revolution in healthcare delivery brought on by big data and cancer genomics is an ethical one." 

Platt is also the organizer of the upcoming ELSI-LHS symposium on November 15th at U-M which explores the “Ethical, Legal and Social Implications of Learning Health Systems”.

Jeffrey DeWitt, PhD

Fellow

Jeff DeWitt completed a PhD in Social Psychology in 2017 while working in Dr. Gretchen Chapman's Medical Decision Making Lab at Rutgers University. Broadly, Jeff's research is focused on the interplay between social cognition and behavioral decision making with an emphasis on healthcare applications. In particular, he has investigated how our representations and predictions of others' beliefs and goals can influence our own in altruistic medical contexts such as whether to donate blood or receive a flu shot. 

Last Name: 
DeWitt

Jennifer Skillicorn, DrPH, MPH

Research Associate

Jennifer joined CBSSM in August 2017. She works with Dr. Susan Goold and community partners on grant funded research projects related to evaluating Medicaid expansion and its impact on beneficiaries through the Healthy Michigan Plan and ways in which to engage minority and underserved communities in setting priorities for community health.

Last Name: 
Skillicorn

CBSSM Seminar: Timothy R. B. Johnson, M.D.

Tue, October 03, 2017, 3:00pm
Location: 
NCRC, Building 10, G065

Timothy R. B. Johnson, M.D.
Arthur F. Thurnau Professor and Chair, Department of Obstetrics and Gynecology
Bates Professor of the Diseases of Women and Children
Professor of Obstetrics and Gynecology and Women’s Studies
Research Professor, CHGD

Title: Global Health Ethics and Reproductive Justice: Breadth and Depth in CBSSM

Global Health Ethics and Reproductive Justice (in this instance sexual rights and gender equity, specifically gender and sexual harassment/assault in Academic Medical Centers) appear to be areas where a number of CBSSM members have interest, expertise and are working inter-disciplinarily in domains that will differentiate CBSSM nationally and internationally. Could and should these develop into CBSSM thematic interests? Whatever the case, they will remain topics of significant interest across CBSSM and are worthy of broad discussion and  understanding.

CBSSM Seminar: Peter Jacobson, J.D., M.P.H.

Tue, October 10, 2017, 3:00pm
Location: 
NCRC, Building 16, Room 266C

Peter Jacobson, J.D., M.P.H.
Professor of Health Law and Policy
Director, Center for Law, Ethics, and Health

Title:  Addressing Health Equity Through Health in All Policies Initiatives.

Scholars and public health advocates have expressed optimism about the potential for Health in All Policies (HiAP) initiatives to improve both health equity and population health. HiAP is a collaborative approach across multiple sectors. In a qualitative study to assess these concepts, we found considerable variation across the sites on: how HiAP and equity initiatives are defined and governed; the integration of equity as a core goal; institutional capacity; and the determination of actual policy changes. We found a general migration from a HiAP-centered strategy to one based more on health equity. Regardless of the specific nomenclature, the implementation focus was directed more toward changing practices than policies.

 

CBSSM was well-represented at the annual American Society for Bioethics & Humanities (ASBH) in Kansas City, MO (Oct 19-22) and the Society for Medical Decision Making (SMDM) in Pittsburgh, PA (Oct 22-25).

At ASBH, Andrew Shuman, Susan Goold, Kayte Spector-Bagdady, Janice Firn, Kerry Ryan, Michele Gornick, Stephanie Kukora, Naomi Laventhal, and Christian Vercler presented.

At SMDM, Michele Gornick, Sarah Hawley, and Dean Shumway presented. Several CBSSM alumni also presented.
 

CBSSM Seminar: Roi Livne, PhD

Wed, November 08, 2017, 3:00pm
Location: 
NCRC, Building 16, Room 266C

Roi Livne, PhD
Assistant Professor, Sociology

Title: “The New Economy of Dying: Palliative Care, Morality, and Finance in the Age of Excess”

Abstract: This talk argues that over the past 40 years, a new economy has emerged around end-of-life care: one seeking to control, cap, and limit both spending and treatment near the end of life. Built around the expertise of Hospice and Palliative Care, this economy draws on the moral conviction that near the end of life, less treatment (and consequently, less spending) is better. Based on a historical analysis and ethnographic fieldwork in three California hospitals, Livne examines the interactive work that palliative care clinicians do with severely ill patients and their families, trying to facilitate their voluntary consent to pursue less life-sustaining and life-prolonging treatments.

 

Pages